Zydus Life gets final USFDA approval to manufacture, market ulcer drug, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

​​​The approval granted by the US Food and Drug Administration (USFDA) is to manufacture and market Sucralfate Tablets of strength 1 gram, Zydus Lifesciences said in a regulatory filing. The drug will be manufactured at the group’s topical manufacturing facility at SEZ, Ahmedabad, it added., ​​​The approval granted by the US Food and Drug Administration (USFDA) is to manufacture and market Sucralfate Tablets of strength 1 gram, Zydus Lifesciences said in a regulatory filing. The drug will be manufactured at the group’s topical manufacturing facility at SEZ, Ahmedabad, it added., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *